Possible new Adaptin Bio shares

APTNDilution

Known so far: no new shares from the prospectus covers read · no effective shelf · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today none, no effective shelf
How this is worked out

Shelf room: none. No shelf registration on EDGAR was declared effective in the last 3 years, so a sale needs a new registration or a private placement. Sources: public float, as of Jun 30, 2025.

What could become new Adaptin Bio (APTN) shares, from its 10-Q, 10-K, S-1 or 424B filings.

Read so far: the cover share count (9.2M shares, +9% from 8.5M on Aug 13, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-1 registration filings.

Shares outstanding

9.2M

Nov 2024 to Aug 2026: from 5.0M to 9.2M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.